HiringNot enough data
We need a relevant verified event before scoring this dimension.
WB
AI Biotechnology · New York, New York, USA
Waypoint Bio
Current work outlook
Waypoint Bio closed a $20 million Series A led by Amplify Partners. The company plans to expand its AI and spatial-biology platform, build clinical-development capabilities and move its lead cell-therapy programs toward trials, while adding former CTRL-Labs and Meta Reality Labs leader Patrick Kaifosh as CTO.
Updated June 1, 2026 · Evidence from public sources
Flags outlook69/ 100Positive
1 verified signal in this assessment
Why this score
Built from company events, not anonymous ratings.
The recent evidence is constructive, but the specific role and team still matter. The score weighs signal recency and source confidence. It is a decision aid—not a verdict on culture or a specific team.
StabilityNot enough data
We need a relevant verified event before scoring this dimension.
Financial healthNot enough data
We need a relevant verified event before scoring this dimension.
InnovationNot enough data
We need a relevant verified event before scoring this dimension.
What moved the outlook
Company timeline
What changed—and why it matters
Read events in order and look for repeated momentum or recurring risk.
Filter in all signals ↗Waypoint Bio raises $20M to expand its AI platform and clinical capabilities
Waypoint Bio closed a $20 million Series A led by Amplify Partners. The company plans to expand its AI and spatial-biology platform, build clinical-development capabilities and move its lead cell-therapy programs toward trials, while adding former CTRL-Labs and Meta Reality Labs leader Patrick Kaifosh as CTO.
Employee impact
Read full analysis →This is a positive growth signal for candidates combining machine learning, spatial biology, automation and clinical development. The company is still at an early and scientifically risky stage, so applicants should verify runway, near-term milestones and whether their position is funded through the next clinical inflection point.